ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

Oxaliplatin

Also written as “oxaliplatin”, “Oxaliplatin (SR96669)” and “oxaliplatin (OXA), levofolinate calcium (l-LV), 5-FU, panitumumab”.

Its studies are mostly in Colorectal Neoplasms · Stomach Neoplasms · Pancreatic Neoplasms · Rectal Neoplasms · Carcinoma, Hepatocellular, led by 9 companies.

Drug pageOxaliplatin: every studyMany companies study it; this page follows only the 66 they lead. All 854 studies, academic ones too, with its approvals and label.
Furthest: phase 4, since Aug 10, 200566 company-led studies, 2 open or runningNext primary completion: Mar 22, 2027 (phase 1)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Sanofi360 open or runningphase 4since Aug 10, 2005Jan 6, 2001none ahead
Hoffmann-La Rocheits history only201 open or runningphase 4since Dec 18, 2007Sep 15, 2003Mar 22, 2027phase 1 · NCT06624085
Prologue Research Internationalits history only30 open or runningphase 3since Jun 5, 2003May 6, 2001none ahead
Pfizerits history only21 open or runningphase 3since Oct 5, 2020Nov 6, 2007none ahead
Criteriumits history only10 open or runningphase 2since Sep 24, 2019Sep 24, 2019none ahead
GlaxoSmithKlineits history only10 open or runningphase 1since Sep 27, 2007Sep 27, 2007none ahead
Nang Kuang Pharmaceuticalits history only10 open or runningphase 2since Mar 28, 2011Mar 28, 2011none ahead
NovoCureits history only10 open or runningno phasesince Feb 20, 2020Feb 20, 2020none ahead
Sirtex Medicalits history only10 open or runningphase 3since Aug 13, 2008Aug 13, 2008none ahead

Also a collaborator on its studies: Exelixis, Novartis, Clovis Oncology, Johnson & Johnson, Ono Pharmaceutical, Merck KGaA, Darmstadt, Germany, Eli Lilly, Parexel, Halozyme Therapeutics, BioLineRx, AbbVie, Zai Lab, Amgen, Bristol-Myers Squibb, Regeneron Pharmaceuticals and Yakult Honsha.

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and studies of Sanofi only; the figures above count every company.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

Before these, 19 studies since Jan 6, 2001.

  1. Dec 12, 2006Phase 3 study in Stomach NeoplasmsNCT00411229 · 1,035 enrolled · China, Korea, Republic of, Taiwan
  2. Jan 11, 2007Phase 2 study in Rectal NeoplasmsNCT00421824 · 108 enrolled · Spain
  3. Feb 16, 2007Phase 2 study in Nasopharyngeal NeoplasmsNCT00436800 · 41 enrolled · Hong Kong
  4. May 9, 2007Phase 3 study in Carcinoma, HepatocellularNCT00471965 · 371 enrolled · China, Korea, Republic of, Taiwan and more
  5. Jul 10, 2007Phase 1 study in AdenocarcinomaNCT00499850 · 18 enrolled · Australia
  6. Nov 15, 2007Phase 2 study in Carcinoma, HepatocellularNCT00559455 · 38 enrolled · Korea, Republic of
  7. Jan 28, 20084 phase 2 studiesNCT00612495, NCT00611962, NCT00611754 and 1 more
  8. Oct 28, 2008Phase 2 study in Uterine NeoplasmsNCT00782041 · 11 enrolled · Thailand
  9. Dec 31, 2008Phase 2 study in Stomach NeoplasmsNCT00816543 · 41 enrolled · Korea, Republic of
  10. Sep 28, 2009Phase 2 study in Colorectal NeoplasmsNCT00988897 · Canada
  11. Apr 29, 2010Phase 3 study in Pancreatic NeoplasmsNCT01121848 · 108 enrolled · Canada
  12. Nov 19, 2010Phase 3 study in Carcinoma, HepatocellularNCT01245582
  13. Jan 10, 2012Phase 3 study in Stomach NeoplasmsNCT01515748 · 530 enrolled · Korea, Republic of
  14. Sep 13, 2013Phase 2 study in Colorectal Cancer MetastaticNCT01955629 · 4 enrolled · Italy

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 36 Sanofi leads, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT01955629Colorectal Cancer Metastatic · Italy2TerminatedMar 20154
NCT01515748Stomach Neoplasms · Korea, Republic of3CompletedJan 21, 2019530
NCT01245582Carcinoma, Hepatocellular3WithdrawnFeb 20140
NCT01121848Pancreatic Neoplasms · Canada3CompletedOct 2013108
NCT00988897Colorectal Neoplasms · Canada2WithdrawnMay 20120
NCT00816543Stomach Neoplasms · Korea, Republic of2CompletedMay 201241
NCT00782041Uterine Neoplasms · Thailand2TerminatedAug 200311
NCT00612495Endometrial Neoplasms · France2Completed31
NCT00611962Neoplasms, Germ Cell and Embryonal · France2Completed27
NCT00611754Head and Neck Neoplasms · France2Completed15
NCT00611507Stomach Neoplasms · Colombia2Completed21
NCT00559455Carcinoma, Hepatocellular · Korea, Republic of2CompletedJan 201038
NCT00499850Adenocarcinoma · Australia1CompletedJun 200618
NCT00471965Carcinoma, Hepatocellular · China, Korea, Republic of, Taiwan and more3CompletedMar 2010371
NCT00436800Nasopharyngeal Neoplasms · Hong Kong2CompletedOct 200841
NCT00421824Rectal Neoplasms · Spain2CompletedNov 2010108
NCT00411229Stomach Neoplasms · China, Korea, Republic of, Taiwan3CompletedNov 20121,035
NCT00403624Rectal Neoplasms2CompletedNov 200538
NCT00399750Colorectal Neoplasms · United States2Completed373
NCT00382720Stomach Neoplasms · United States, Belgium, France and more2CompletedApr 2010275
NCT00356122Carcinoma, Non-Small-Cell Lung · United States2CompletedAug 201053
NCT00296816Ovarian Neoplasms · United States2CompletedAug 2011132
NCT00280618Carcinoma, Hepatocellular2CompletedNov 2006
NCT00275210Colonic Neoplasms · Australia, Austria, Belgium and more3CompletedApr 20032,246
NCT00271271Carcinoma, Non-Small-Cell Lung · France2Completed40
NCT00263354Stomach Neoplasms2CompletedJul 200620
NCT00263055Colonic Neoplasms · China, Hong Kong, Korea, Republic of and more4CompletedJun 2005
NCT00263029Rectal Neoplasms2CompletedMar 200718
NCT00261092Pancreatic Neoplasms · Korea, Republic of2Completed48
NCT00259363Rectal Neoplasms · Spain2TerminatedJun 200646
NCT00174616Rectal Neoplasms · Belgium, France, Germany and more2CompletedNov 200787
NCT00174564Biliary Tract Neoplasms2CompletedSep 200667
NCT00129870Colorectal Neoplasms · United States4Terminated180
NCT00094965Gastrointestinal Neoplasms · United States2CompletedAug 200743
NCT00012389Colorectal Neoplasms · United States, Brazil, Canada and more3Completed
NCT00008281Colorectal Neoplasms · United States, Canada3UNKNOWN

How it is read

Names in the registry

  • “Oxaliplatin”, 51 entries
  • “oxaliplatin”, 20 entries
  • “Oxaliplatin (SR96669)”, 3 entries
  • “oxaliplatin (OXA), levofolinate calcium (l-LV), 5-FU, panitumumab”, 3 entries
  • “OXALIPLATIN”, 3 entries

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.